The strength of the evidence linking concurrency to HIV epidemic severity in southern and
eastern Africa led the Joint United Nations Programme on HIV/AIDS and the Southern …

Summary Background Raltegravir (MK-0518) is an HIV-1 integrase inhibitor with potent in-
vitro activity against HIV-1 strains including those resistant to currently available …

Ninety percent of HIV-1-infected people worldwide harbour non-subtype B variants of HIV-1.
Yet knowledge of resistance mutations in non-B HIV-1 and their clinical relevance is limited …

Objective: To investigate the origin and to reconstruct the onset date of the HIV-1 subtype C
epidemic in Brazil. Design: Three independent datasets of subtype C sequences isolated …

Current evidence suggests good treatment response and comparable drug resistance
evolution in HIV-1 B and non-B infected patients, with increasingly emerging differences …

This study aimed to analyze human immunodeficiency virus (HIV) mutation profiles related
to antiretroviral resistance following therapeutic failure, and the distribution of hiv subtypes in …

Viral and host factors are known to play a role in the different patterns of AIDS progression.
The cocirculation of HIV-1 subtypes B, F1, BBR, and BF1; the occasional detection of HIV-1 …

The HIV-1 subtype C has spread efficiently in the southern states of Brazil (Rio Grande do
Sul, Santa Catarina and Paraná). Phylogeographic studies indicate that the subtype C …

Previous studies indicate that the HIV-1 subtype C epidemic in southern Brazil was initiated
by the introduction of a single founder strain probably originating from east Africa. However …

The HIV‐1 genetic variability in Bahia state, Brazil, was investigated. DNA samples from 229
and 213 HIV‐1‐infected individuals were analyzed using the heteroduplex mobility assay …